Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2011, Vol. 31 Issue (7): 1-7    DOI:
    
Construction and Identification of a Lentiviral Vector Expressing Semaphorin 4D
SUN Qiang-ming, PAN Yue, ZHAO Yu-jiao, CHEN Jun-ying, SHI Hai-jing, MA Shao-hui
Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases, Kunming 650118, China
Download: HTML   PDF(943KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: To construct a lentiviral vector expressing Semaphorin 4D to investigate the role of Semaphorin 4D in angiogenesis. Methods: Semaphorin 4D sequence was amplified from the Jurkat cell cDNA, inserted into pWPI GW vector and identified by DNA sequencing. The packing cell line (human embryonic kidney 293T cell) was cotransfected with pWPI GW/Sema4D, pVSVG and pSPAX. The recombinant lentivirus was packaged and amplified, followed by infection of 293T and HUVEC cells. The expression level of Semaphorin 4D gene was analyzed by Western blot and immunofluresence staining. A Boyden chamber migration assay was performed to establish the biological significance of Semaphorin 4D. Results: The recombinant lentiviral vector expressing Semaphorin 4D was successfully constructed. Western blot and immunofluresence staining results demonstrated that Semaphorin 4D was successfully expressed in 293T and HUVEC cells infected by recombinant lentivirus expressing Semaphorin 4D. Boyden chamber migration assay results showed that enhanced endothelial cell migration is induced by Sema4D-expressing Hela cells.



Key wordsSemaphorin 4D      Lentivirus      Angiogenesis      Gene therapy     
Received: 21 February 2011      Published: 25 July 2011
ZTFLH:  Q819  
Cite this article:

SUN Qiang-ming, PAN Yue, ZHAO Yu-jiao, CHEN Jun-ying, SHI Hai-jing, MA Shao-hui. Construction and Identification of a Lentiviral Vector Expressing Semaphorin 4D. China Biotechnology, 2011, 31(7): 1-7.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2011/V31/I7/1


[1] Swiercz J M, Kuner R, Behrens J, et al. Plexin-B1 Directly Interacts with PDZ-RhoGEF/LARG to Regulate RhoA and Growth Cone Morphology. Neuron, 2002, 35(1):51-63.


[2] Conrotto P, Valdembri D, Corso S,et al. Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood, 2005, 105(11):4321-4329.

[3] Basile J R, Barac A, Zhu T, et al. Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res, 2004, 64(15):5212-5224.


[4] Sierra J R, Corso S, Caione L, et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med, 2008, 205(7):1673-1685.


[5] Basile J R, Castilho R M, Williams V P, et al. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci USA, 2006, 103(24):9017-9022.


[6] Sun Q M, Nawabi-Ghasimi F, Basile J R. Semaphorins in vascular development and head and neck squamous cell carcinoma-induced angiogenesis. Oral Oncol, 2008, 44(6):523-531.


[7] Matrai J, Chuah M K, VandenDriessche T. Recent advances in lentiviral vector development and applications. Mol Ther, 2010, 18(3):477-490.


[8] Tiscornia G, Singer O, Verma I M. Production and purification of lentiviral vectors. Nat Protoc, 2006, 1(1):241-245.


[9] Kolodkin A L, Matthes D J, Goodman C S. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell, 1993, 75(7):1389-1399.

[10] Dittgen T, Nimmerjahn A, Komai S, et al.Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc Natl Acad Sci USA, 2004, 101(52):18206-18211.

[11] Cockrell A S, Kafri T.Gene delivery by lentivirus vectors. Mol Biotechnol, 2007, 36(3):184-204.

[12] Cartier N, Hacein-Bey-Abina S, Bartholomae C C, et al.Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science, 2009, 326(5954):818-823.

[1] ZHAO Xiao-yu,XU Qi-ling,ZHAO Xiao-dong,AN Yun-fei. Enhancing Lentiviral Vector Transduction Efficiency for Facilitating Gene Therapy[J]. China Biotechnology, 2021, 41(8): 52-58.
[2] LIN Lu,HU Li-jun,HUANG Yi-yun,CHEN Lu,HUANG Mao,PENG Qi,HU Qin,ZHOU Lan. S100A6 Promotes Angiogenesis Through Recruiting and Activating Macrophages[J]. China Biotechnology, 2020, 40(5): 7-14.
[3] HUANG Sheng, YAN Qi-tao, XIONG Shi-lin, PENG Yi-qi, ZHAO Rui. Construction of CHD5 Gene Overexpressing Lentiviral Vector Based on CRISPR/Cas9-SAM System and the Effect of CHD5 on Proliferation, Migration and Invasion in T24 Cells[J]. China Biotechnology, 2020, 40(3): 1-8.
[4] XU Ying-yong. Current Status and Challenges of Gene Therapy Products[J]. China Biotechnology, 2020, 40(12): 95-103.
[5] CHEN Qing-yu,WANG Xian-zhong,ZHANG Jiao-jiao. Application of Gene Technology in the Treatment of Type 2 Diabetes Mellitus[J]. China Biotechnology, 2020, 40(11): 73-81.
[6] Lu JIAN,Ying-hui HUANG,Tian-ya LIANG,Li-min WANG,Hong-tao MA,Ting ZHANG,Dan-yang LI,Ming-lian WANG. Generation of JAK2 Gene Knockout K562 Cell Line by CRISPR/Cas9 System[J]. China Biotechnology, 2019, 39(7): 39-47.
[7] Zhan-bing MA,Jie DANG,Ji-hui YANG,Zheng-hao HUO,Guang-xian XU. Establishment and Application of Dual Fluorescent Labeling Multi-functional Autophagy Flux Monitoring System Based on Lentiviral System[J]. China Biotechnology, 2019, 39(5): 88-95.
[8] Ya-li HAN,Guang-heng YANG,Yan-wen CHEN,Xiu-li GONG,Jing-zhi ZHANG. The Optimization of Self-deleting Lentiviral Vector Carrying Human β-globin Gene and Promoter[J]. China Biotechnology, 2018, 38(7): 50-57.
[9] CAO Rong-yue, YU Min-xia, ZHANG Xin-li, LI Man-man, MIAO Zi-tao, JIN Liang. Construction,Expression,Purification of VEGFⅡ/GRP Fusion Protein and the Effects on RM-1 Prostate Tumor in Mice[J]. China Biotechnology, 2016, 36(8): 9-15.
[10] LIU Yi-xuan, BIAN Zhen, MA Hong-mei. Progress and Prospect of Cancer Gene Therapy[J]. China Biotechnology, 2016, 36(5): 106-111.
[11] TAO Chang-li, HUANG Shu-lin. Advances in Research on Optimization of Transgenic TCR Pairing in TCR Gene Therapy[J]. China Biotechnology, 2016, 36(3): 87-92.
[12] DAI Yu huan, XU Yao, LUO Ying, DAI Yang, SHI Wei lin, XU Yao. The Transcriptional Regulation of Ca2+ Channel Mediated by Myocardin in H9C2 Cell[J]. China Biotechnology, 2016, 36(11): 1-6.
[13] LIU Rui-qi, WANG Wei-wei, WU Yong-yan, ZHAO Qiu-yun, WANG Yong-sheng, QING Su-zhu. Research Progress of CRISPR-Cas9 and Its Application in Gene Therapy[J]. China Biotechnology, 2016, 36(10): 72-78.
[14] TANG Wen-yan, LUAN Zuo. Biological Characteristics and Clinical Application of Endothelial Progenitor Cells[J]. China Biotechnology, 2016, 36(10): 86-93.
[15] ZHU Shao-yi, GUAN Li-hong, LIN Jun-tang. CRISPR-Cas9 System and Its Applications in Disease Models[J]. China Biotechnology, 2016, 36(10): 79-85.